AMERICAN BOARD OF OPHTHALMOLOGY – Trademark Portfolio
Entity Type: 03
AMERICAN BOARD OF OPHTHALMOLOGY holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include AMERICAN BOARD OF OPHTHALMOLOGY, THE AMERICAN BOARD OF OPHTHALMOLOGY 1916 EX OBSCURIS LUX, and THE AMERICAN BOARD OF OPHTHALMOLOGY EX OBSCURIS LUX 1916. The owner is based in Doylestown, PA.
P.O. Box 1887
Doylestown, PA 18901
Showing of trademarks Trademarks
Trademark Classifications
AMERICAN BOARD OF OPHTHALMOLOGY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does AMERICAN BOARD OF OPHTHALMOLOGY have?
AMERICAN BOARD OF OPHTHALMOLOGY has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does AMERICAN BOARD OF OPHTHALMOLOGY file in?
AMERICAN BOARD OF OPHTHALMOLOGY files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are AMERICAN BOARD OF OPHTHALMOLOGY's most well-known trademarks?
AMERICAN BOARD OF OPHTHALMOLOGY's registered trademark portfolio includes well-known marks such as AMERICAN BOARD OF OPHTHALMOLOGY, THE AMERICAN BOARD OF OPHTHALMOLOGY 1916 EX OBSCURIS LUX, and THE AMERICAN BOARD OF OPHTHALMOLOGY EX OBSCURIS LUX 1916. These are among 4 currently registered trademarks in the portfolio.
What is AMERICAN BOARD OF OPHTHALMOLOGY's trademark registration success rate?
AMERICAN BOARD OF OPHTHALMOLOGY has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.